GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins September 04, 2024
Displaying entries 3951 - 4000 of 39437 in total
PDB ID UniProt ID ▲ Title Descriptor
7MZG 7MZG SARS-CoV-2 receptor binding domain bound to Fab PDI 42
7MZH 7MZH SARS-CoV-2 receptor binding domain bound to Fab WCSL 119
7MZI 7MZI SARS-CoV-2 receptor binding domain bound to Fab WCSL 129
7MZJ 7MZJ SARS-CoV-2 receptor binding domain bound to Fab WCSL 129 and Fab PDI 93
7MZK 7MZK SARS-CoV-2 receptor binding domain bound to Fab WCSL 129 and Fab PDI 96
7MZL 7MZL SARS-CoV-2 receptor binding domain bound to Fab PDI 210
7MZM 7MZM SARS-CoV-2 receptor binding domain bound to Fab PDI 215
7MZN 7MZN SARS-CoV-2 receptor binding domain bound to Fab PDI 231
7N04 7N04 Crystal structure of the apo F240 antibody fragment
7N0A 7N0A Structure of Human Leukaemia Inhibitory Factor with Fab MSC1
7N0G 7N0G CryoEm structure of SARS-CoV-2 spike protein (S-6P, 1-up) in complex with sybodies (Sb45)
7N0H 7N0H CryoEM structure of SARS-CoV-2 spike protein (S-6P, 2-up) in complex with sybodies (Sb45)
7N0U 7N0U Complex of recombinant Bet v 1 with Fab fragment of REGN5713
7N19 7N19 DR3 in complex with Aspergillus nidulans NAD-dependent histone deacetylase hst4 peptide
7N28 7N28 Cryo-EM structure of broadly neutralizing V2-apex-targeting antibody J033 in complex with HIV-1 Env
7N2N 7N2N TCR-antigen complex AS4.2-PRPF3-HLA*B27
7N2O 7N2O AS4.2-YEIH-HLA*B27
7N2P 7N2P AS4.3-RNASEH2b-HLA*B27
7N2Q 7N2Q AS4.3-YEIH-HLA*B27
7N2R 7N2R AS4.3-PRPF3-HLA*B27
7N2S 7N2S AS3.1-PRPF3-HLA*B27
7N3I 7N3I Crystal structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment C098
7N3T 7N3T TrkA ECD complex with designed miniprotein ligand
7N4I 7N4I Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2057.
7N4J 7N4J Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2173.
7N4M 7N4M Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2151.
7N5H 7N5H Cryo-EM structure of broadly neutralizing antibody 2-36 in complex with prefusion SARS-CoV-2 spike glycoprotein
7N62 7N62 SARS-CoV-2 Spike (2P) in complex with C12C9 Fab (NTD local reconstruction)
7N64 7N64 SARS-CoV-2 Spike (2P) in complex with G32R7 Fab (RBD and NTD local reconstruction)
7N65 7N65 Complex structure of HIV superinfection Fab QA013.2 and BG505.SOSIP.664
7N8H 7N8H SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement
7N8I 7N8I SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20)
7N8Q 7N8Q Rhesusized RV305 DH677.3 Fab bound to Clade A/E 93TH057 HIV-1 gp120 core.
7NAM 7NAM LRP6_E1 in complex with Lr-EET-3.5
7ND3 7ND3 EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-40 Fab
7ND4 7ND4 EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-88 Fab COVOX-158 heavy chain, COVOX-158 light chain, Spike glycoprotein
7ND5 7ND5 EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-150 Fab COVOX-158 heavy chain, COVOX-158 light chain, Spike glycoprotein
7ND6 7ND6 EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-40 Fab COVOX-158 heavy chain, COVOX-158 light chain, Spike glycoprotein
7ND7 7ND7 EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-316 Fab COVOX-158 heavy chain, COVOX-158 light chain, Spike glycoprotein
7ND8 7ND8 EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-384 Fab COVOX-158 heavy chain, COVOX-158 light chain, Spike glycoprotein
7ND9 7ND9 EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-253H55L Fab COVOX-158 heavy chain, COVOX-158 light chain, Spike glycoprotein
7NDA 7NDA EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-253H55L Fab COVOX-158 heavy chain, COVOX-158 light chain, Spike glycoprotein
7NDB 7NDB EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-253H165L Fab COVOX-158 heavy chain, COVOX-158 light chain, Spike glycoprotein
7NDC 7NDC EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-159 COVOX-158 heavy chain, COVOX-158 light chain, Spike glycoprotein
7NDD 7NDD EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-159 COVOX-158 heavy chain, COVOX-158 light chain, Spike glycoprotein
7NE0 7NE0 Structure of the ternary complex between Netrin-1, Repulsive-Guidance Molecule-B (RGMB) and Neogenin
7NE0 7NE0 Structure of the ternary complex between Netrin-1, Repulsive-Guidance Molecule-B (RGMB) and Neogenin
7NEF 7NEF Fucosylated linear peptide Fln65 bound to the fucose binding lectin LecB PA-IIL from Pseudomonas aeruginosa at 1.5 Angstrom resolution
7NEG 7NEG Crystal structure of the N501Y mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-269 Fab
7NEH 7NEH Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-269 Fab

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024